679 related articles for article (PubMed ID: 32728216)
1. Lysosome-targeting chimaeras for degradation of extracellular proteins.
Banik SM; Pedram K; Wisnovsky S; Ahn G; Riley NM; Bertozzi CR
Nature; 2020 Aug; 584(7820):291-297. PubMed ID: 32728216
[TBL] [Abstract][Full Text] [Related]
2. LYTACs: An Emerging Tool for the Degradation of Non-Cytosolic Proteins.
Ramadas B; Kumar Pain P; Manna D
ChemMedChem; 2021 Oct; 16(19):2951-2953. PubMed ID: 34296796
[TBL] [Abstract][Full Text] [Related]
3. Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras.
Ahn G; Riley NM; Kamber RA; Wisnovsky S; Moncayo von Hase S; Bassik MC; Banik SM; Bertozzi CR
Science; 2023 Oct; 382(6668):eadf6249. PubMed ID: 37856615
[TBL] [Abstract][Full Text] [Related]
4. Harnessing the Lysosomal Sorting Signals of the Cation-Independent Mannose-6-Phosphate Receptor for Targeted Degradation of Membrane Proteins.
Yu J; Li H; Fang T; Yun C; Liu X; Xu J; Jiang X; Cai X
J Am Chem Soc; 2023 Aug; 145(34):19107-19119. PubMed ID: 37552887
[TBL] [Abstract][Full Text] [Related]
5. IGF2 Peptide-Based LYTACs for Targeted Degradation of Extracellular and Transmembrane Proteins.
Mikitiuk M; Barczyński J; Bielski P; Arciniega M; Tyrcha U; Hec A; Lipińska AD; Rychłowski M; Holak TA; Sitar T
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005242
[TBL] [Abstract][Full Text] [Related]
6. Degradation from the outside in: Targeting extracellular and membrane proteins for degradation through the endolysosomal pathway.
Ahn G; Banik SM; Bertozzi CR
Cell Chem Biol; 2021 Jul; 28(7):1072-1080. PubMed ID: 33770486
[TBL] [Abstract][Full Text] [Related]
7. Emerging protein degradation strategies: expanding the scope to extracellular and membrane proteins.
Lin J; Jin J; Shen Y; Zhang L; Gong G; Bian H; Chen H; Nagle DG; Wu Y; Zhang W; Luan X
Theranostics; 2021; 11(17):8337-8349. PubMed ID: 34373745
[TBL] [Abstract][Full Text] [Related]
8. Expression, purification, and characterization of human mannose-6-phosphate receptor - Extra cellular domain from a stable cell line utilizing a small molecule biomimetic of the mannose-6-phosphate moiety.
Dwyer B; Lundberg D; Iskenderian A; Strack-Logue B; Pescatore B; Norton AW; Xu J; Meiyappan M; Concino MF; Zhang B
Protein Expr Purif; 2020 Jun; 170():105589. PubMed ID: 32027983
[TBL] [Abstract][Full Text] [Related]
9. LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation.
Ahn G; Banik SM; Miller CL; Riley NM; Cochran JR; Bertozzi CR
Nat Chem Biol; 2021 Sep; 17(9):937-946. PubMed ID: 33767387
[TBL] [Abstract][Full Text] [Related]
10. Multivesicular endosomes containing internalized EGF-EGF receptor complexes mature and then fuse directly with lysosomes.
Futter CE; Pearse A; Hewlett LJ; Hopkins CR
J Cell Biol; 1996 Mar; 132(6):1011-23. PubMed ID: 8601581
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor immunotherapy using engineered bacterial outer membrane vesicles fused to lysosome-targeting chimeras mediated by transferrin receptor.
Su LY; Tian Y; Zheng Q; Cao Y; Yao M; Wang S; Xu W; Xi C; Clocchiatti A; Nie G; Zhou H
Cell Chem Biol; 2024 Jun; 31(6):1219-1230.e5. PubMed ID: 38309277
[TBL] [Abstract][Full Text] [Related]
12. Development of Oligomeric Mannose-6-phosphonate Conjugates for Targeted Protein Degradation.
Stevens CM; Zhou Y; Teng P; Rault LN; Liao Y; Tang W
ACS Med Chem Lett; 2023 Jun; 14(6):719-726. PubMed ID: 37312839
[TBL] [Abstract][Full Text] [Related]
13. Protein targeting by tyrosine- and di-leucine-based signals: evidence for distinct saturable components.
Marks MS; Woodruff L; Ohno H; Bonifacino JS
J Cell Biol; 1996 Oct; 135(2):341-54. PubMed ID: 8896593
[TBL] [Abstract][Full Text] [Related]
14. LYST affects lysosome size and quantity, but not trafficking or degradation through autophagy or endocytosis.
Holland P; Torgersen ML; Sandvig K; Simonsen A
Traffic; 2014 Dec; 15(12):1390-405. PubMed ID: 25216107
[TBL] [Abstract][Full Text] [Related]
15. Conjugation with glucagon like peptide-1 enables targeted protein degradation.
Zhu L; Zhou Y; Zhang B; Luo Y; Fang C; Yan X; Cai Y; Jiang L; Ge J
Bioorg Chem; 2023 Dec; 141():106908. PubMed ID: 37827016
[TBL] [Abstract][Full Text] [Related]
16. Lysosome Targeting Chimaeras for Glut1-Facilitated Targeted Protein Degradation.
Luo J; Gao Q; Tan K; Zhang S; Shi W; Luo L; Li Z; Khedr GE; Chen J; Xu Y; Luo M; Xing Q; Geng J
J Am Chem Soc; 2024 Jul; 146(26):17728-17737. PubMed ID: 38899504
[TBL] [Abstract][Full Text] [Related]
17. Effective degradation of EGFR
Qu X; Liu H; Song X; Sun N; Zhong H; Qiu X; Yang X; Jiang B
Eur J Med Chem; 2021 Jun; 218():113328. PubMed ID: 33773286
[TBL] [Abstract][Full Text] [Related]
18. Nano-LYTACs for Degradation of Membrane Proteins and Inhibition of CD24/Siglec-10 Signaling Pathway.
Wang K; Yu A; Liu K; Feng C; Hou Y; Chen J; Ma S; Huang L; Dai X
Adv Sci (Weinh); 2023 May; 10(13):e2300288. PubMed ID: 36866919
[TBL] [Abstract][Full Text] [Related]
19. Multivalent Aptamer-Based Lysosome-Targeting Chimeras (LYTACs) Platform for Mono- or Dual-Targeted Proteins Degradation on Cell Surface.
Duan Q; Jia HR; Chen W; Qin C; Zhang K; Jia F; Fu T; Wei Y; Fan M; Wu Q; Tan W
Adv Sci (Weinh); 2024 May; 11(17):e2308924. PubMed ID: 38425146
[TBL] [Abstract][Full Text] [Related]
20. The kinetics of mannose 6-phosphate receptor trafficking in the endocytic pathway in HEp-2 cells: the receptor enters and rapidly leaves multivesicular endosomes without accumulating in a prelysosomal compartment.
Hirst J; Futter CE; Hopkins CR
Mol Biol Cell; 1998 Apr; 9(4):809-16. PubMed ID: 9529379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
